S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
BREAKING: Tiny biotech successfully treats blindness (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
BREAKING: Tiny biotech successfully treats blindness (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
BREAKING: Tiny biotech successfully treats blindness (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
Indonesia is set to launch Southeast Asia's first high-speed railway, largely funded by China
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
BREAKING: Tiny biotech successfully treats blindness (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
BREAKING: Tiny biotech successfully treats blindness (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
BREAKING: Tiny biotech successfully treats blindness (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
Indonesia is set to launch Southeast Asia's first high-speed railway, largely funded by China
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
BREAKING: Tiny biotech successfully treats blindness (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
BREAKING: Tiny biotech successfully treats blindness (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
BREAKING: Tiny biotech successfully treats blindness (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
Indonesia is set to launch Southeast Asia's first high-speed railway, largely funded by China
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
BREAKING: Tiny biotech successfully treats blindness (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
BREAKING: Tiny biotech successfully treats blindness (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
BREAKING: Tiny biotech successfully treats blindness (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
Indonesia is set to launch Southeast Asia's first high-speed railway, largely funded by China
OTCMKTS:PHGUF

Pharming Group (PHGUF) Stock Forecast, Price & News

$1.30
0.00 (0.00%)
(As of 09/29/2023 ET)
Compare
Today's Range
$1.30
$1.30
50-Day Range
$1.23
$1.40
52-Week Range
$0.96
$1.59
Volume
N/A
Average Volume
485 shs
Market Capitalization
$848.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

PHGUF stock logo

About Pharming Group (OTCMKTS:PHGUF) Stock

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's commercialized product is RUCONEST, a plasma-free rhC1INH protein replacement therapy for the treatment acute hereditary angioedema (HAE) attacks. It also engages in the development of leniolisib for the treatment of activated phosphoinositide 3-kinase delta syndrome; OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE; and alpha-glucosidase therapy for the treatment of Pompe and fabry diseases. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. is headquartered in Leiden, the Netherlands.

PHGUF Price History

PHGUF Stock News Headlines

Buy This Stock for AI Tidal Wave (not NVDA)
The internet boom made more millionaires than any tech  - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.
H.C. Wainwright Keeps Their Buy Rating on Pharming Group (PHAR)
Pharming Group NV American Depositary Shares Repr 10 Shs Reg S
Pharming Group N.V. reports Q2 results
RBC Capital Sticks to Their Buy Rating for Pharming Group (PHGUF)
Buy This Stock for AI Tidal Wave (not NVDA)
The internet boom made more millionaires than any tech  - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.
Pharming Group N.V.: Notice of First Quarter 2023 Results
Notice of First Quarter 2023 Results
Pharming Group N.V.: Notice of Full Year 2022 financial results
Notice of Full Year 2022 financial results
See More Headlines
Receive PHGUF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharming Group and its competitors with MarketBeat's FREE daily newsletter.

PHGUF Company Calendar

Last Earnings
3/05/2015
Today
10/01/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:PHGUF
CIK
N/A
Employees
332
Year Founded
N/A

Profitability

Net Income
$13.67 million
Pretax Margin
7.29%

Debt

Sales & Book Value

Annual Sales
$205.62 million
Cash Flow
$0.04 per share
Book Value
$0.31 per share

Miscellaneous

Free Float
N/A
Market Cap
$848.13 million
Optionable
Not Optionable
Beta
1.10
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Dr. Sijmen de Vries M.B.A. (Age 64)
    M.D., MBA, Pres, CEO & Exec. Director
    Comp: $1.18M
  • Mr. Jeroen Wakkerman (Age 54)
    Chief Financial Officer
  • Ms. Mireille Sanders M.Sc. (Age 55)
    Chief Operations Officer
  • Susanne Embleton
    Investor Relations Mang.
  • Mr. Ruud Van Outersterp (Age 59)
    Chief Ethics & Compliance Officer
  • Dr. Anurag Relan M.D. (Age 51)
    MPH, Chief Medical Officer
  • Mr. Stephen Toor (Age 52)
    Chief Commercial Officer & GM Americas
  • Dr. Alexander Breidenbach M.B.A.
    Chief Bus. Officer
  • Dr. Bruno M. L. Giannetti (Age 71)
    Consultant













PHGUF Stock - Frequently Asked Questions

How have PHGUF shares performed in 2023?

Pharming Group's stock was trading at $1.1499 at the beginning of 2023. Since then, PHGUF stock has increased by 13.1% and is now trading at $1.30.
View the best growth stocks for 2023 here
.

How were Pharming Group's earnings last quarter?

Pharming Group (OTCMKTS:PHGUF) issued its earnings results on Thursday, March, 5th. The biotechnology company reported $0.05 earnings per share for the quarter, beating analysts' consensus estimates of $0.04 by $0.01. Pharming Group had a negative trailing twelve-month return on equity of 8.15% and a negative net margin of 7.96%.

What is Pharming Group's stock symbol?

Pharming Group trades on the OTCMKTS under the ticker symbol "PHGUF."

How do I buy shares of Pharming Group?

Shares of PHGUF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pharming Group's stock price today?

One share of PHGUF stock can currently be purchased for approximately $1.30.

How much money does Pharming Group make?

Pharming Group (OTCMKTS:PHGUF) has a market capitalization of $848.13 million and generates $205.62 million in revenue each year. The biotechnology company earns $13.67 million in net income (profit) each year or ($0.03) on an earnings per share basis.

How many employees does Pharming Group have?

The company employs 332 workers across the globe.

How can I contact Pharming Group?

Pharming Group's mailing address is Darwinweg 24, Leiden P7, 2333 CR. The official website for the company is www.pharming.com. The biotechnology company can be reached via phone at (171) 524-7400, via email at investor@pharming.com, or via fax at 31-0-71-524-7445.

This page (OTCMKTS:PHGUF) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -